High throughput screening with custom peptide arrays - axxelera
The axxelera Sars-Cov-2 peptide array contains the complete spike protein sequence of the novel coronavirus in overlapping linear and discontinuous peptide sequences which combine segments that are adjacent not in the primary, but only in the tertiary structure of the virus. We can deliver these peptides with free N-terminus, or in constrained form by cyclization. In cooperation with our partners from AI industry we developed an algorithm which reduces the whole human peptidome, derived from 23 000 human proteins, to a set of 100 000 sequences which represent 80% of the human proteome on the level of subsequences of various length. The AMS is a fully automated synthesis machine of ultrahigh-density peptide microarrays. With more than 20 years of experience in the field of high-throughput screenings, we can assist your studies. In addition to our own technological developments, we built a network of equipment and service companies in the fields of protein, peptide, and antibody studies.
Keywords
Industries
Where is axxelera located?
The company axxelera is located in Eggenstein-Leopoldshafen, Baden-Württemberg, Germany. It's worth noting that the company may has more corporate locations
How many employees does axxelera approximately have?
As of the latest available information axxelera has around 1-10 employees worldwide.
In which industries does axxelera mainly work?
The company axxelera has it's main focus in the industries of Biotechnology
CDI Laboratories, Inc.
United States
1-10 Employees
Antigen Discovery
United States
11-50 Employees
2004
Aapptec, LLC
United States
11-50 Employees
2005
peptides&elephants GmbH
Germany
11-50 Employees
2001
AnaSpec
United States
51-100 Employees
1993
Aptum Biologics Ltd.
United Kingdom
1-10 Employees
2013
Bostonmolecules Inc.
United States
11-50 Employees
2016
Space Peptides
China
Topics which have been searched by others and may be interesting for you: